$27.26 $0.75 (2.8%)

08:00 PM EST on 01/17/20

PetMed Express, Inc. (NASDAQ:PETS)

CAPS Rating: 3 out of 5

A nationwide pet pharmacy, that markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses direct to the consumer.

Current Price $27.26 Mkt Cap $544.8M
Open $0.00 P/E Ratio 20.94
Prev. Close $27.26 Div. (Yield) $1.08 (4.0%)
Daily Range $0.00 - $0.00 Volume 905,939
52-Wk Range $22.91 - $27.61 Avg. Daily Vol. 468,284


How do you think NASDAQ:PETS will perform against the market?

Add Stock to CAPS Watchlist

All Players

882 Outperform
30 Underperform

All-Star Players

181 Outperform
5 Underperform

Wall Street

1 Outperform
0 Underperform

Top NASDAQ:PETS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

jed71 (99.85)
Submitted March 11, 2019

The shorts have been holding on to their dream of riches from this little stub for a long, long time. The short interest continues to hover at a very high 48% of float. And so far, they've been absolutely correct. This company's stock has come down… More

zharriott (79.75)
Submitted August 04, 2014

The company operates in a growing industry, has some decent branding ability, and could potentially grow to be a household name for medication for pets.Sadly, this most likely will not be happening.I don't understand how in 2014 management believes… More


Fools bullish on NASDAQ:PETS are also bullish on:

Fools bearish on NASDAQ:PETS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PETS.


Member Avatar Transfigurement (31.17) Submitted: 8/17/2019 4:30:39 PM : Outperform Start Price: $16.51 NASDAQ:PETS Score: +51.51

Bow wows and kitty cats


Member Avatar whodidntante (36.38) Submitted: 6/10/2019 4:24:07 PM : Outperform Start Price: $18.05 NASDAQ:PETS Score: +34.89

This is one of those plays/investments where, IF you are a consumer of the product then owning the stock can pay for that product and then some. At $17.50/share, the yield is over 6%. If you're going to add to a companies top line for pet supplies and pet meds (aka, you buy pet products), why not let the company pay you back? You can buy any given product from over a dozen online retailers all of them within a very small competitive price range; but PETS is the one stock with a dividend, never mind the only one giving it back at 6%. With a dividend of $1.08/share and good chances for future dividend hikes (yes, even in today's challenge of margin pressures), a few hundred shares provides a few hundred bucks or a full year's outlay for a pet's food and meds. IF you have the means to invest, even every veterinarian and animal shelter would be wise to get their supplies from PETS and happily cash that dividend check. Sure Chewy may be the larger and more recognizable retailer name, but that doesn't mean they will put every other retailer out of business. On the contrary, when an investor looks at the companies performance and sees losses vs profit, debt vs cash, and junk grade ownership vs a 6% yield; PETS is clearly the better investment (especially, if you're already a consumer of the product). Quite arguably, if you are a pet owner PETS paints a very compelling argument to buy some shares of PETS and start purchasing your pet supplies through PetMed Express.


Member Avatar jed71 (99.85) Submitted: 3/11/2019 9:48:22 AM : Outperform Start Price: $20.00 NASDAQ:PETS Score: +15.69

The shorts have been holding on to their dream of riches from this little stub for a long, long time. The short interest continues to hover at a very high 48% of float. And so far, they've been absolutely correct. This company's stock has come down from nearly $50 a share last June to under $21 a share, a close to 2 year low.

The problem here is a lot of investors seem to think that the competition for this firm, namely Chewy and Amazon, is going to continue to crush their margins. Some have called this a value trap. I just don't see it. They've been around for more than 20 years and have an extremely solid customer base. Chewy is also aggressively pricing products to switch customers, and take away new business. I don't think this will continue forever. Competition is a huge risk, but I think it is very well priced in at this juncture.

Fundamentally speaking, this company looks extremely strong. Their ROE is a very strong 34%. Cash flow is about 12X current price. They have no debt. Balance sheet is crazy strong and they have good flexibility to make necessary strategic decisions. They pay a 5.5% dividend. They hold cash of about $93MM on their balance, about $4.50 per share. I think they stabilize at $20 or maybe a little lower. I am putting this out as a marker to keep an eye on it. I personally think the bad news is priced in. Any good news and this will move much, much higher. I haven't bought yet, but if it dips under $20 I will most likely open a small position.


Find the members with the highest scoring picks in PETS.

Score Leader


TMFCop (89.65) Score: +321.89

The Score Leader is the player with the highest score across all their picks in PETS.

Member Name Member
Call Time
Score Commentary
oman33 83.64 9/11/2006 Outperform 3M $5.88 +363.67% +172.51% +191.16 0 Comment
Fanjiemeng 86.05 12/6/2011 10/27/2017 Outperform 5Y $6.07 +349.15% +163.01% +186.14 0 Comment
creditimpress < 20 7/26/2012 Outperform 5Y $6.35 +329.00% +144.25% +184.75 0 Comment
ValueMsn 78.01 12/5/2011 Outperform 5Y $6.19 +340.49% +161.71% +178.79 0 Comment
burgerandsoda 62.80 5/8/2007 Outperform 3Y $6.62 +311.79% +133.36% +178.44 1 Comment
soncho53 84.29 10/3/2006 Outperform 1Y $6.16 +342.49% +165.15% +177.34 0 Comment
laqny121 < 20 10/3/2006 Outperform 1Y $6.16 +342.49% +165.15% +177.34 0 Comment
masisgn < 20 5/8/2007 Outperform 1Y $6.67 +308.74% +132.99% +175.76 0 Comment
taylor2123 < 20 10/19/2011 Outperform 5Y $6.11 +346.08% +171.25% +174.84 0 Comment
mpaulsen6 38.80 7/30/2012 Outperform 3Y $6.59 +313.52% +139.64% +173.88 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PETS.